Zobrazeno 1 - 10
of 12
pro vyhledávání: '"A W G van der Velden"'
Autor:
Saskia le Cessie, Nick van Es, Michiel Coppens, Karina Meijer, Suzanne C Cannegieter, Saskia Middeldorp, Menno V Huisman, Frederikus A Klok, Geert-Jan Geersing, Annette W G van der Velden, Elske M van den Akker-van Marle, Albert T A Mairuhu, M Elske van den Akker-van Marle, Laura M Faber, Tjerk de Nijs, Remy H H Bemelmans, Coen van Guldener, Marcel A van de Ree, Marieke J.H. Wermer, Tessa Elling, Carolien van Netten, Milou A M Stals, Rick Roos, J Louise I Burggraaf-van Delft, Nienke van Rein, Jan-Willem K van den Berg, Coty Y Bruggeman, Marissa Cloos-van Balen, Matthijs Eefting, Yvonne Ende-Verhaar, Wouter K de Jong, Fleur Kleijwegt, Ted Koster, Cees Kroon, Saskia Kuipers, Jenneke Leentjens, Dieuwke Luijten, Ilse Schrover, Janneke Swart-Heikens, Yavuz Bilgin, Marleen Goddrie, Pieter Jobse, Suzanne Jong, Brianne Murphy, Carla Boekholt, Danick Werner, Laura Kratz, Marjolein Kremers, Monique Schilders, Gideon Hajer, Bas Langeveld, Saskia Teunisse-de Recht, Annemiek Bogerd, Ymke Broers, Stan Kolman, Sanjay Sankatsing, Lenneke van Tol, Edith Beishuizen, Shantie Bharatsingh, Edith Boersma, Annemarie van der Kraan-Donker, Sabine van Arnhem, Fransien Croon-de Boer, Ad Dees, J P (Hanneke) van Embden, Roxane Heller, Merel Hoogendorp, Roel Jonkhoff, Roel J J M van de Laar, Corry Leunis-de Ruiter, Patricia Scherpenisse-Klopstra, Tom L H Stellema, Kim Warink, Lizanne E van den Akker, Eleonora C Camilleri, Tess R C Huibregtse, Ingeborg de Jonge, Ruben Y Kok, Inger N Kunnekes, Lejla Mahic, Hinke C Nagtegaal, Petra J Noordijk, Hülya Oztürk, Alexia M van der Ploeg, Vibeke Schmidt, Anne-Marie Schuitemaker, Vera C Slootweg, Mark J R Smeets, Milou Thibaudier, Marco Dam, Swopkje de Jong, Hanneke van der Velde, Evertine Abbink, Carlinda Bresser, Simone Sissing, Soerajja Bhoelan, Èmese Heijkoop, Francien Huisman, Mark Lenssen, Anja B U Makelburg, Karen H Thedinga, Marja A J Voskuilen, Femke Yspeerd, Sandra Brookman, Titia Lamberts, Inge Paas, Janneke Swart Heikens, Janneke van den Brink, Aline van de Vendel, Ellis S. van Etten
Publikováno v:
BMJ Open, Vol 14, Iss 3 (2024)
Introduction Patients with a first venous thromboembolism (VTE) are at risk of recurrence. Recurrent VTE (rVTE) can be prevented by extended anticoagulant therapy, but this comes at the cost of an increased risk of bleeding. It is still uncertain whe
Externí odkaz:
https://doaj.org/article/a64444f5ad18406f879dce721db0685e
Publikováno v:
BMJ Open, Vol 10, Iss 11 (2020)
Objectives In the ‘Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism’ (SELECT-D) trial, rivaroxaban showed relatively low venous thromboembolism (VTE) recurrence but hi
Externí odkaz:
https://doaj.org/article/edfb428896fd46a093fbc6d67ecf3f7e
Autor:
Maaike Kok, Gertruud F. M. van der Werff, Jenske I. Geerling, Jaap Ruivenkamp, Wies Groothoff, Annette W. G. van der Velden, Monique Thoma, Jaap Talsma, Louk G. P. Costongs, Reinold O. B. Gans, Pauline de Graeff, Anna K. L. Reyners
Publikováno v:
BMC Palliative Care, Vol 17, Iss 1, Pp 1-8 (2018)
Abstract Background Advance Care Planning (ACP) and its documentation, accessible to healthcare professionals regardless of where patients are staying, can improve palliative care. ACP is usually performed by trained facilitators. However, ACP conver
Externí odkaz:
https://doaj.org/article/7f91f78c5c5c4debbca3e670238bb269
Autor:
Gabriela G F, van der Schoot, Harm L, Ormel, Nico-Derk L, Westerink, Anne M, May, Sjoerd G, Elias, Yoran M, Hummel, Joop D, Lefrandt, Peter, van der Meer, Joost P, van Melle, Boelo J, Poppema, Joyce M A, Stel, Annette W G, van der Velden, Aline H, Vrieling, Johan B, Wempe, Marcel G, Ten Wolde, Marcel, Nijland, Elisabeth G E, de Vries, Jourik A, Gietema, Annemiek M E, Walenkamp
Publikováno v:
JACC. CardioOncology. 4(4)
Despite the widely acknowledged benefit of exercise for patients with cancer, little evidence on the optimal timing of exercise on adverse effects of cancer treatment is available.The aim of this study was to determine whether an exercise interventio
Publikováno v:
BMJ Open, 10(11):039057. BMJ PUBLISHING GROUP
BMJ Open, Vol 10, Iss 11 (2020)
BMJ Open
BMJ Open, Vol 10, Iss 11 (2020)
BMJ Open
ObjectivesIn the ‘Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism’ (SELECT-D) trial, rivaroxaban showed relatively low venous thromboembolism (VTE) recurrence but hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765fbb86208f26f198cd8bf9fbbff0a1
https://research.rug.nl/en/publications/01bc8193-f6ce-47e1-a516-136655f7cb7a
https://research.rug.nl/en/publications/01bc8193-f6ce-47e1-a516-136655f7cb7a
Autor:
Bronno van der Holt, Anders Waage, Niels W.C.J. van de Donk, E. (Vera) J. M. Mattijssen, M. (Rineke) B. L. Leys, Annette W. G. van der Velden, Mark-David Levin, Harm Sinnige, Klaas G. van der Hem, Morten Salomo, Bea Tanis, Einar Haukås, Ulf-Henrik Mellqvist, Matthijs Westerman, Rolf Brouwer, Pieter Sonneveld, Saskia K. Klein, Astrid Gruber, Gerard M. J. Bos, Marian Stevens-Kroef, Markus Hansson, Damian L. Szatkowski, Wendy Deenik, Torben Plesner, Sonja Zweegman, Marc Durian, Heleen Visser-Wisselaar, Juleon Coenen
Publikováno v:
Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, Bos, G M J, Levin, M-D, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S K, Tanis, B C, Szatkowski, D L, Brouwer, R E, Westerman, M, Leys, M R B L, Sinnige, H A M, Haukås, E, van der Hem, K G, Durian, M F, Mattijssen, E V J M, van de Donk, N W C J, Stevens-Kroef, M J P L, Sonneveld, P & Waage, A 2016, ' Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma ', Blood, vol. 127, no. 9, pp. 1109-1116 . https://doi.org/10.1182/blood-2015-11-679415
Blood, 127(9), 1109-1116. American Society of Hematology
Blood, 127(9), 1109-1116. The American Society of Hematology
Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, Bos, G M J, Levin, M-D, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S K, Tanis, B C, Szatkowski, D L, Brouwer, R E, Westerman, M, Leys, M B L, Sinnige, H A M, Haukas, E, van der Hem, K G, Durian, M F, Mattijssen, E J M, van de Donk, N W C J, Stevens-Kroef, M J P L, Sonneveld, P & Waage, A 2016, ' Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma ', Blood, vol. 127, no. 9, pp. 1109-1116 . https://doi.org/10.1182/blood-2015-11-679415
Blood, 127, 1109-16
Blood, 127, 9, pp. 1109-16
Blood, 127(9), 1109-1116. American Society of Hematology
Blood, 127(9), 1109-1116. The American Society of Hematology
Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, Bos, G M J, Levin, M-D, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S K, Tanis, B C, Szatkowski, D L, Brouwer, R E, Westerman, M, Leys, M B L, Sinnige, H A M, Haukas, E, van der Hem, K G, Durian, M F, Mattijssen, E J M, van de Donk, N W C J, Stevens-Kroef, M J P L, Sonneveld, P & Waage, A 2016, ' Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma ', Blood, vol. 127, no. 9, pp. 1109-1116 . https://doi.org/10.1182/blood-2015-11-679415
Blood, 127, 1109-16
Blood, 127, 9, pp. 1109-16
The combination of melphalan, prednisone, and thalidomide (MPT) is considered standard therapy for newly diagnosed patients with multiple myeloma who are ineligible for stem cell transplantation. Long-term treatment with thalidomide is hampered by ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27be0ae01cb43dea87bdd45a3473c8b5
https://portal.findresearcher.sdu.dk/da/publications/767d554b-0302-426c-b3cf-03650e95cbc9
https://portal.findresearcher.sdu.dk/da/publications/767d554b-0302-426c-b3cf-03650e95cbc9
Autor:
R. van Beek, Douwe H. Biesma, O. de Weerdt, Maartje Los, A. W G van der Velden, Jacqueline M. Stouthard, A. Beeker, Matthijs Westerman, A. Meerveld-Eggink, Ger T. Rijkers, Guus F. Rimmelzwaan, A.M.T. van der Velden, Marten R. Nijziel
Publikováno v:
Annals of Oncology, 22(9), 2031-2035. Elsevier Ltd.
Background: Patients receiving chemotherapy are at increased risk for influenza virus infection. Little is known about the preferred moment of vaccination during chemotherapy. Patients and methods: Breast cancer patients received influenza vaccinatio
Autor:
L, Saes, W G, Peters, R, Schaafsma, D J, van Spronsen, A W G, van der Velden, W F, van den Bosch, E, Meijer
Publikováno v:
The Netherlands journal of medicine. 73(3)
The standardised mortality ratio (SMR) is a quality indicator used to measure quality of care in the Netherlands. It is subject to much criticism, which was the reason to study the value of the SMR as a quality indicator for the treatment of acute le
Autor:
M. Los, Mathias Leys, A.M.T. van der Velden, A. Meerveld-Eggink, M.R. Nijziel, A. W G van der Velden, Guus F. Rimmelzwaan, Ger T. Rijkers, M. Wumkes, Douwe H. Biesma, Matthijs Westerman, A. Beeker
Publikováno v:
Vaccine, 31(52), 6177-6184. Elsevier
Background Higher rates of hospitalization and mortality are described in oncology patients with influenza virus infection compared to the general population. Yearly influenza vaccination is recommended for patients treated with chemotherapy. The opt
Autor:
Lynnda J N, Wind, Annette W G, van der Velden, Gilles F H, Diercks, Hendri H, Pas, Marcel F, Jonkman
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 154
A 53-year-old man with non-Hodgkin lymphoma developed red, flaky skin, which was initially suggestive of a drug reaction. He also had pneumonia, for which he was admitted for antibiotic treatment. During admission the skin picture changed and blister